Denervation has been shown to impair the ability of insulin to stimulate glycogen synthesis and to a lesser extent glucose transport in rat skeletal muscle. Insulin binding to its receptor, activation of the receptor tyrosine-kinase and phosphatidylinositol 3'-kinase do not appear to be involved. On the other hand, it has been shown that denervation causes an increase in the total diacylglycerol (DAG) content and membrane-associated protein kinase C (PKC) activity. In this paper, we characterize further these changes in PKC and assess other possible signaling abnormalities that might be related to the decrease of glycogen synthesis. The results reveal that PKC ε and θ, but not α, ζ, are increased in the membrane fraction 24 h after denervation, and that the timing of these changes parallel the impaired ability of insulin to stimulate glycogen synthesis. At 24 hr these changes were associated with a 65% decrease in glycogen synthase (GS) activity ratio and decreased electrophoretic mobility indicative of phosphorylation in GS in muscles incubated in the absence of insulin. Incubation of the denervated soleus with insulin for 30 min minimally increased glucose incorporation into glycogen; however, it increased GS activity 3 -fold, to a value still less that of control muscle, and it eliminated the gel shift. In addition, insulin increased the apparent abundance of GSK3 and PP1α in the supernatant fraction of muscle homogenate to control values and it caused the same increases in GSK3 and Akt/PKB phosphorylation and Akt/PKB activity that it did in nondenervated muscle. No alterations in hexokinase I or II activity were observed after denervation; however, in agreement w ith a previous report glucose-6-phosphate levels were diminished in 24 h denervated soleus and they did not increase after insulin stimulation. These results indicate that, alterations in the distribution of PKC ε and θ accompany the impairment of glycogen synthesis in the 24 h denervation soleus. They also indicate that the basal rate of glycogen E-0390-2001.R1 3 synthesis and its stimulation by insulin in these muscles are diminished despite a normal activation of Akt/PKB and phosphorylation of GSK3. The significance o f the observed alterations to GSK3 and PP1α distribution remain to be determined.
INTRODUCTION
Denervation of skeletal muscle for as little as 6-24 h has been shown to impair the ability of insulin to stimulate glycogen synthesis and t o a lesser extent glucose transport (8, 10, 20, 35) .
Although defects in glycogen synthase (GS) activation have been reported (8) , the mechanism by which insulin action is impaired is not clear. Thus, binding of insulin t o its receptor and activation of the receptor tyrosine-kinase (9) and phosphatidylinositol 3'-kinase (PI3K) (11) do not appear to be affected, suggesting that events distal to PI3K activation are involved.
It has been shown that denervation causes an increase in the total diacylglycerol (DAG) content and membrane-associated protein kinase C (PKC) activity (20) . Alterations in the activity and/or distribution of novel (PKC ε and θ) and occasionally conventional PKC isoforms have been demonstrated in skeletal muscle in a variety of insulin resistant states including those induced by fat feeding (33) , fructose ingestion (15) , and glucose infusion (24) . In addition, alterations in PKC distribution have been observed in insulin-resistant muscle of fa/fa and GK rats (1) . Which PKC isoform(s) are altered in the denervated muscle is not known.
It has also been reported that GS activity is impaired in denervated rat muscle both in basal and insulin-stimulated states (8) . GS, the rate-limiting enzyme in glycogen synthesis, is regulated by covalent modification and allosterical regulation (23, 34) . Covalent modification occurs by phosphorylation, as GS can be phosphorylated on at least six residues by a variety of kinases which cumulatively inhibit its activity. One of these kinases, GSK3 is phosphorylated and inactivated by insulin. It has been proposed that this results in the disinhibition of GS by diminishing its phosphorylation (14, 17, 41) .
It has also been suggested that GS dephosphorylation and activation can result from the insulin-stimulated activation of glycogen targeted protein phosphatase-1 (PP1) (29) .
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In the present study we have attempted to address the mechanism of glycogen synthase inhibition following sciatic nerve section by asking the following questions: 1) What are the PKC isoforms responsible for the observed alteration in membrane-associated PKC activity? 2)
Is the timing of changes in PKC distribution consistent with the development of insulin resistance and documented elevation of malonyl-CoA? 3) Do alterations in distal events in the insulin signaling c ascade or in the distribution of GS, GSK3 and PP1alpha occur after denervation. Finally, when initial data confirmed an earlier report that the concentration of glucose-6-phosphate was diminished in the denervated soleus, we asked whether this might be related to a decrease in hexokinase activity. were performed) and 10 mU/ml insulin as indicated. At the end of a 30 min incubation in this medium, muscles were quickly blotted with a piece of gauze and quick-frozen in liquid nitrogen.
MATERIALS AND METHODS

Experimental
The muscles were stored at -80°C until the measurement of glucose disposition and other assays were performed.
Measurement of Glucose Disposition.
[U 14 C]-glucose incorporation in glycogen and lipid and its oxidation to CO 2 were measured as described previously (20) .
PKC Immunoblotting. The processing of muscles used for tissue extraction and PKC solubilization was as described previously (26) . Briefly, muscles (25-35 mg) were homogenized and extracted in 500 µl of an ice-cold homogenizing buffer containing 250 mM sucrose, 50 mM Tris (pH 7.5), 2 mM EDTA, 0.4 mM EGTA, 10 mM dithiothreitol (DTT), 5 µg/ml leupeptin, 4 Assay of glycogen synthase activity and western blot. Muscles were homogenized in 50 mM Hepes (pH 7.8), 10 mM EDTA, and 100 mM NaF plus protease inhibitors then subjected to centrifugation for 10 min at 2,500 xg. Glycogen synthase activity in the supernatant was measured as described previously (6, 25) . Briefly, 25-50 µl of supernatant was assayed in a final volume of 100 µl of glycogen synthase buffer containing 5 mM UDP-glucose and 1 µCi/ml [U-
14 C]UDP-glucose, in both the presence and absence of 10 mM glucose 6 -phosphate (G6P).
Sample were incubated at 37 o C and then placed on ice for 15 min. Ninety µl of the reaction mixture was spotted on GF/A filters, dried for 3 s, and then placed in 70% ethanol on ice. Filters were washed for 20 min at 4 o C and then washed two more times in 70% ethanol at room temperature. Filters were air dried, and [U-14 C]UDP-glucose incorporation into glycogen was measured by liquid scintillation counting. In the western blot, equal amount of protein was loaded, separated by SDS-PAGE, and blotted with anti-GS antibody (a generous gift from Dr. J.
Lawrence Jr, U. of Virginia). GS blots were visualized using horseradish peroxidase (HRP)-conjugated secondary antibody followed by chemoluminescence as outlined by the manufacturer (Amersham Pharmacia, Piscataway, NJ).
GSK3 western blot.
Muscles were weighed (average 25-35 mg) and homogenized in 1 ml of ice cold buffer containing 50 mM Hepes (pH 7.4), 1 mM EGTA, 1 mM EDTA, 10 mM β-glycerolphosphate, 5 mM Sodium pyrophosphate, 100 mM KCl with 1 mM DTT, 0.5 mM Na 3 VO 4 , and 10 µl/ml Protease Inhibitor Cocktail P8340 added just before use. Triton X-100
was added to each sample to achieve a final concentration of 0.5% (v/v) and the sample solublized for 1 hour at 4°C. The resultant lysate was centrifuged at 15,000 xg for 10 minutes and the supernatant was either used in western blot assay for GSK3 or the activity measurement.
PP1α α western blot. For PP1α assay, the processing was as described previously (7). Briefly, muscle was homogenized in PP1α homogenization buffer (50 mM Hepes (pH 7.2), 2 mM EDTA, 0.2% 2 -mercaptoethanol, and 2 mg/ml glycogen) plus 10 µg/ml aprotinin, 1 mM benzamidine, and 0.1 mM phenylmethylsulfonyl fluoride added just before use. The homogenate was centrifuged at 10,000 xg to yield supernatant for western blot assay. In western blot, equal amount of protein was loaded, separated by SDS-PAGE, and blotted with anti-PP1α antibody (a generous gift from Dr. J. Lawrence Jr, U. of Virginia). PP1α blots were visualized using horseradish peroxidase (HRP)-conjugated secondary antibody followed by chemoluminescence as outlined by the manufacturer (Amersham Pharmacia, Piscataway, NJ).
Glucose-6-phosphate measurement. Muscles (25-35 mg) were homogenized in 1 ml ice-cold 6% perchloric acid for 1 min. The precipitated protein was pelleted by centrifugation at 5,000 xg for 15 min.
The supernatant was neutralized with KHCO 3 , and G6P was assayed spectrophotometrically as described by Lowry and Passoneau (27) .
of homogenizing buffer (20 mM Tris-HCl, 900 mM KCl, 10 mM MgCl2, 2 mM EDTA, 10 mM Glucose, and 0.5% Tween-20). The homogenate was centrifuged at 10,000 xg for 30 min and the supernatant was split in half to measure total hexokinase activity and heat-stable hexokinase (hexokinase I). Hexokinase activity was assayed as described by Postic et.al. (31) . Hexokinase II activity was subsequently calculated by subtracting hexokinase I from total hexokinase activity.
Statistical analysis. Data are presented as means ± SEM. Treatment effects were evaluated using a two-tailed Student's t test. A p value <0.05 was considered to be statistically significant.
RESULTS
Impairment of insulin-stimulated glycogen synthesis at 24 h, but not 6 h after denervation in
the soleus muscle. In keeping with previous data (8, 20) , glucose incorporation into glycogen both in the presence and absence of insulin was significantly decreased in the 24 h denervated muscle, whereas glucose incorporation into lipid was enhanced. Six hours after denervation, neither of these alterations was evident (Fig. 1) .
Alteration of nPKC distribution in muscle, 24 h but not 2-12 hr after denervation. As noted previously, an increase in membrane-associated PKC activity has been observed in muscle 24
hours after denervation (20); however, the PKC isoforms responsible for this are not known. To answer this question, the cellular distribution of various PKC isoforms was compared in shamoperated and denervated muscle. Twenty four hours after denervation, the abundance of PKC θ and ε (P<0.05), but not PKC α or ζ was increased in the total homogenate suggesting an increase in net synthesis. As shown in Fig. 2B , this was due to an increase the abundance of these isoforms in the membrane fraction (p<0.05) without a corresponding decrease in the cytosolic fraction.
To evaluate the time course of these changes in PKC distribution, similar studies were performed in muscle taken 2, 6 and 12 hours after denervation (Fig. 3) . In contrast to the finding at 24 hours, no changes in the membrane abundance of PKC θ or ε were found at these times.
Interestingly, at 12 hours, a decrease in the mass of PKC ζ in the membrane fraction was found in both control and denervated muscle suggesting it could be subject to diurnal variation.
The activation of Akt/PKB by insulin is unaffected by denervation. The ability of insulin to activate its receptor tyrosine kinase (9) and PI3K (11) is not diminished in 24-hour denervated muscle. This, plus the differential effect of insulin on glucose incorporation into glycogen and lipid synthesis in these muscles suggest that more distal events in the insulin signaling pathway are involved. As shown in Fig. 4 , this event did not appear to involve Akt/PKB. Thus, both basal Akt/PKB activity and insulin-stimulated activation of this kinase were the same in denervated and control soleus muscles. Likewise, the phosphorylation of serine 473 on Akt/PKB, an indicator of its activation by insulin, was unaffected by denervation.
GS activity is impaired by denervation. The abundance and activity of glycogen synthase were measured in control and 24-h denervated muscles incubated in the presence and absence of insulin. Fig. 5A shows that the activity of the active form of the enzyme (expressed as the activity ratio -G6P/+G6P) was decreased by 60% in denervated muscle incubated with a medium devoid of insulin. Surprisingly insulin caused a greater percentage increase in the activity of GS in the denervated soleus than it did in control muscles although activity was still significantly higher in the control muscle. Total GS activity (Fig. 5B ) was also slightly lower in denervated than in control muscle; although in the presence of insulin this difference was not statistically significant. None of these changes was associated with an alteration in the abundance of GS (Fig. 5C ). On the other hand, an immunoblot of GS showed a gel shift in the denervated soleus that was not observed following incubation with insulin (Fig. 5C ).
Effects of denervation and insulin on GSK3 and PP1α α distribution and GSK3
phosphorylation. The abundance of GSK3 and, to an even greater extent, its phosphorylation on serine 9 were markedly decreased in the 15,000 xg supernatant of 24 h denervated soleus incubated in the absence of insulin (Fig. 6 ). Incubation with insulin reversed both of these abnormalities. As shown in Fig. 7 , denervation caused a similar alteration in PP1α distribution, which was also reversed by insulin.
The concentration of G6P was diminished in denervated muscle both in presence and absence of insulin, whereas hexokinase I and II activities were unchanged. The failure of insulin to stimulate glycogen synthesis in denervated muscle, despite its ability to phosphorylate GSK3 and activate GS, caused us to examine the effect of denervation on the concentration of G6P. In keeping with the findings of Burant et al. (8) , the concentration of G6P was diminished by 50%
in the 24 h denervated soleus and insulin failed to increase its concentration as it did in a control muscle ( Figure 8A ). Thus, after insulin stimulation, the concentration of G6P was 70% lower in the denervated soleus. As shown in Figure 8B , these differences were not paralleled by differences in the activity of hexokinase I or II between control and denervated muscle.
DISCUSSION
The increases in the concentration of DAG and PKC activity have been associated with insulin resistance in skeletal muscle in several model systems including the denervated muscle (20) . Denervation causes a dichotomy in insulin action: the ability of insulin to stimulate glucose incorporation into glycogen is markedly inhibited, whereas, its ability to direct glucose into DAG and lipids is enhanced. These findings, plus the observation that membrane-associated PKC activity is increased 24 hours after denervation (20) , led to the hypothesis that an increased formation of complex lipids, such as DAG, could initiate the events leading to insulin resistance (impaired glycogen synthesis) in denervated muscle by causing a sustained activation of one or more conventional or novel PKC isoforms (12, 20) . Thus, at various time points after sciatic nerve sectioning we examined changes in glucose disposition, PKC isoform distribution, and the activity of metabolic enzymes and signaling molecules in order to better understand how insulinstimulated glycogen synthesis is inhibited.
The distribution of individual PKC isoforms in denervated soleus muscle was examined by western blot. We focused on PKC α, ε, and θ since they are the predominant isoforms expressed in skeletal muscle and changes in their distribution have been found in a variety of insulin-resistant states (1, 15, 24, 33) , and on the atypical isoform PKC ζ which is thought to play an important role in the regulation of glucose transport (38) and protein synthesis (28) by insulin. The results revealed that only the DAG-sensitive, novel PKC isoforms θ and ε were affected by denervation; both their abundance in the whole homogenate and the membrane fraction were increased at 24 hours (Fig. 2B) . In contrast, no changes in the mass of PKC α and PKC-ζ were observed. Given that PKC-α is also DAG-sensitive, it is unclear why it did not respond in similar fashion. One possibility is that changes in DAG did not co-localize with PKC α; alternatively, changes in intracellular calcium as well as DAG might be required to alter its membrane targeting. Irrespective of the explanation, the observation that the changes in PKC-θ and PKC-ε abundance and distribution are not observed at 2 and 12 h after denervation, when insulin stimulated glycogen synthesis is still normal, suggest that t hese alterations in PKC could play a causal role. The increase in total lipid synthesis also temporally correlates with a repartioning of FFA into complex lipids such as PA and DAG as might be expected following a rise in malonyl-CoA (32) . While this increase in malonyl-CoA peaked between 6 and 8 hours following denervation, it persisted at twice control levels for more than 24 hours.
Activation of novel PKCs might impair insulin action by a number of mechanisms. Thus, increased PKC activity has been shown in certain settings to serine phosphorylate the insulin receptor leading to decreases in the ability of insulin to stimulate glucose transport and various of its metabolic effects (2, 5, 18, 39) . Against such a mechanism being operative in 24 h denervated muscle, inhibition of early steps in the insulin signaling cascade (receptor tyrosine kinase, PI3K, Akt/PKB) was not observed in these muscles (9, 11) , this study). In addition, insulin-stimulated g lycogen synthesis was severely impaired after denervation, whereas the ability of insulin to stimulate glucose transport and overall glucose utilization was only minimally diminished and its ability to stimulate glucose incorporation into lipid was enhanced (20) , this study). Collectively, these findings suggest that the decrease in glycogen synthesis in denervated muscle 1) is not secondary to decreased glucose transport and 2) if it is related to impaired signaling, either a distal event in the cascade mediated by insulin or changes in an early event are involved. Whether the observed alteration in PKC θ and ε contributed to these changes remains to be determined; although, it is noteworthy that incubation of the soleus with 1 µM of phorbol dibutyrate for 1 hour, which activates both cPKC and nPKC isoforms, inhibits insulin-stimulated glycogen synthesis, but not glucose transport (26, 37) . Furthermore, inhibition of the insulin receptor tyrosine kinase and PI3K were minimal in these muscles; whereas a clear cut decrease in Akt/PKB phosphorylation was observed (26) .
In 24 hour denervated solei incubated in a medium devoid of insulin, the activity of the active form of GS is diminished by 60% and electrophoretic mobility of GS is altered, consistent with phosphorylation. Unexpectedly, these changes were associated with a decrease in the abundance of both PP1α and GSK3 in the 15,000 xg supernatant of the muscle homogenate and with a decreased phosphorylation of GSK3 in this fraction. Presumably the net effect of these changes was to increase GS phosphorylation.
Although insulin only minimally stimulated glycogen synthesis in the 24 h denervated soleus, it activated Akt/PKB and GS to the same extent that it did in non-denervated muscles. In addition, it eliminated the gel shift of GS seen in the absence of insulin and it restored the abundance of PP1α and GSK3 in the muscle supernatant to control values. The net effect appeared to be activation of GS most l ikely related to its dephosphorylation. Studies to assess translocation between the supernatant and pellet fraction of these molecules are needed to explore the basis for these changes in subcellular distribution.
In keeping with an earlier study by Burant and coworkers (8), insulin did not increase the concentration of G6-P in denervated muscle as it did in control muscle ( Figure 8A ). As a result, the concentration of G6-P in the denervated muscle incubated with insulin was only 25% of that of a control muscle. This persistently low concentration of G6-P offers one explanation for the limited effect of insulin on the rate of glucose incorporation into glycogen in situ in the incubated soleus following denervation (Figure 1) , despite its pronounced effect on GS activity ( Figure 5 ).
Interestingly, this result points to the fact that 24 hour denervation did not affect the ability of insulin to increase the intrinsic activity of GS as had been previously thought (7) . The reason for this f ailure to increase the G6-P concentration despite an apparently normal stimulation of glucose uptake and glycolysis (13, 20) in the denervated soleus is not known. The data in this study suggest it is not attributable to a decrease in hexokinase activity with the caveat that this reflects the intrinsic activity of the enzyme. The efficient phosphorylation of glucose by hexokinase requires its coupling to mitochondria and this is increased by muscle contraction (3, 32, 42) . Therefore, one might speculate that denervation results in a less efficient coupling and a decrease in the in situ activity of hexokinase. Another hypothetical possibility is that insulinstimulated glucose transport directed to glycogen, versus down t he glycolytic pathway, is selectively depressed. There is no data in the literature relevant to this subject; however, it has been demonstrated that insulin and exercise recruit GLUT-4 transporter from different pools (30) . Whether these transporters differentially direct glucose taken up by the muscle cell to different sites has not been studied.
That denervation leads to an impairment of insulin stimulated glycogen synthesis and sometimes glucose transport in muscle has long been appreciated (8, 10, 35) . The results of different studies are somewhat difficult to compare because of such variables as muscle type, duration of denervation and nutritional state (8, 35, 36) . In experiment with rat diaphragm, one day after denervation, Smith and Lawrence (35) observed a 50% decrease in glucose incorporation into glycogen and a decreased activity ratio for GS, both in the presence and absence of insulin. In addition, they failed to observe a decrease in 2-deoxyglucose uptake at this time, but did so 3 days following denervation. Later studies suggest this secondary decrease in glucose transport is related to late occurring decreases in the abundance of glucose transporter-investigators demonstrated that in an incubated epitrochlearis muscle prelabeled with 32 P, activation of glycogen synthase by insulin is associated with the dephosphorylation of GS on at least 2 sites. In muscle denervated for 3 days, they found that the ability of insulin to do this was lost as was its ability to activate GS (36) . Studies in muscle denervated for one day were not reported.
In conclusion, our results show that the inhibition of insulin stimulated glycogen synthesis in rat soleus muscle 24 hours after denervation correlates with altered distribution of PKC-θ and PKC-ε and an increase in glucose incorporation into lipids. The reason that the ability of insulin to stimulate glucose incorporation into glycogen is depressed in these muscles remains an enigma. Data from this study suggest that it is not due to an impaired ability of insulin to alter Akt/PKB and GSK3 phosphorylation or to activate glycogen synthase. The results also suggest that a redistribution of GSK3 and PP1α occurs in denervated muscle;
however, its relation to the pathophysiology of impaired glycogen synthesis is unclear, but may relate to the phosphorylation state of GS. 
